| Cathy Sue Layne, MD | |
|
923 N 2nd St, Ste 105, Albemarle, NC 28001-3317 | |
| (704) 403-1877 | |
| Not Available |
| Full Name | Cathy Sue Layne |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 18 Years |
| Location | 923 N 2nd St, Albemarle, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750572079 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2018-00734 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Charlotte-mecklenburg Hospital Authority | 2961310685 | 488 |
News Archive
A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.
Exercise testing can be a powerful tool for diagnosing chronic heart and lung conditions and measuring responses to treatment, according to new research published in the European Respiratory Journal.
Alaskan native children are experiencing increased rates of serious infections caused by strains of pneumococcal bacteria that are not covered by the current childhood pneumococcal vaccine, indicating the importance of ongoing surveillance of vaccine effectiveness, according to a study in the current issue of JAMA.
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
› Verified 4 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.
Exercise testing can be a powerful tool for diagnosing chronic heart and lung conditions and measuring responses to treatment, according to new research published in the European Respiratory Journal.
Alaskan native children are experiencing increased rates of serious infections caused by strains of pneumococcal bacteria that are not covered by the current childhood pneumococcal vaccine, indicating the importance of ongoing surveillance of vaccine effectiveness, according to a study in the current issue of JAMA.
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cathy Sue Layne, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Cathy Sue Layne, MD 923 N 2nd St, Ste 105, Albemarle, NC 28001-3317 Ph: (704) 403-1877 |
News Archive
A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.
Exercise testing can be a powerful tool for diagnosing chronic heart and lung conditions and measuring responses to treatment, according to new research published in the European Respiratory Journal.
Alaskan native children are experiencing increased rates of serious infections caused by strains of pneumococcal bacteria that are not covered by the current childhood pneumococcal vaccine, indicating the importance of ongoing surveillance of vaccine effectiveness, according to a study in the current issue of JAMA.
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).
› Verified 4 days ago
Douglas Smith, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 350 Pee Dee Ave, Suite A, Albemarle, NC 28001 Phone: 704-983-8868 | |
Olav Nilender, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4480 | |
Dr. Dianne Frances Mcqueen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1000 N 1st St, Suite 1, Albemarle, NC 28001 Phone: 704-983-2117 Fax: 704-983-2636 | |
Dr. Mariel Melissa Litz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 350 Pee Dee Ave, Suite A, Albemarle, NC 28001 Phone: 704-986-1500 Fax: 336-641-3089 | |
Dr. David William Schmidt, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 923 N 2nd St, Ste 102, Albemarle, NC 28001 Phone: 704-982-0122 Fax: 704-982-0125 | |
Terica Natasha Young, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 923 N 2nd St, Ste 105, Albemarle, NC 28001 Phone: 704-403-1877 | |
David Brent Joye, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 N 1st St Ste 1, Albemarle, NC 28001 Phone: 704-983-2117 Fax: 704-983-2636 |